A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes

  • Authors:
    • Shaoling Zhou
    • Xiaomei Meng
    • Shuyan Wang
    • Ruizhen Ren
    • Weikai Hou
    • Kuixiang Huang
    • Hongli Shi
  • View Affiliations

  • Published online on: May 26, 2016     https://doi.org/10.3892/etm.2016.3394
  • Pages: 1097-1102
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Insulin resistance and reduced β-cell glucose sensitivity are present in patients with type 2 diabetes. In the present study, we investigated the changes in β-cell function in patients with type 2 diabetes during a 3‑year follow‑up study. A total of 48 patients with early‑onset type 2 diabetes (EOD) and 55 patients with late‑onset type 2 diabetes (LOD) were enrolled. Weight, height, waist circumference, hip circumference, blood pressure and plasma levels of lipids, glucose, fasting serum C‑peptide (CPR0) and serum C‑peptide 6 min after glucagon stimulation (CPR6) were measured. In addition, islet β‑cell secretory activity was detected. Subjects with EOD had lower Systolic blood pressure (SBP), diastolic blood pressure (DBP), body mass index (BMI), fasting CPR0, CPR6 and greater glycated hemoglobin A1c (HbA1c), triglyceride (TG) compared with subjects with LOD. CPR0, CPR6 and TG were decreased in both EOD and LOD groups 3 years later. The ratio of β‑cell function failure was 29.17 and 10.91% in the EOD and LOD groups, respectively, and there was significant difference between the two groups. A positive correlation was identified between the CPR0 and waist‑hip ratio, HbA1c in the EOD group. A similar positive correlation was observed between CPR0 and BMI in the LOD group. Collectively, islet β‑cell function has declined in patients with EOD, and this change may be more evident when compared with those with LOD.
View Figures
View References

Related Articles

Journal Cover

August-2016
Volume 12 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou S, Meng X, Wang S, Ren R, Hou W, Huang K and Shi H: A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes. Exp Ther Med 12: 1097-1102, 2016
APA
Zhou, S., Meng, X., Wang, S., Ren, R., Hou, W., Huang, K., & Shi, H. (2016). A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes. Experimental and Therapeutic Medicine, 12, 1097-1102. https://doi.org/10.3892/etm.2016.3394
MLA
Zhou, S., Meng, X., Wang, S., Ren, R., Hou, W., Huang, K., Shi, H."A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes". Experimental and Therapeutic Medicine 12.2 (2016): 1097-1102.
Chicago
Zhou, S., Meng, X., Wang, S., Ren, R., Hou, W., Huang, K., Shi, H."A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes". Experimental and Therapeutic Medicine 12, no. 2 (2016): 1097-1102. https://doi.org/10.3892/etm.2016.3394